Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56dim and CD56bright cells and memory-like CD57+NKG2C+CD56dim cells

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 5, 2014, Pages 463-471

  Lima, Josenilson F ^a   Oliveira, Luanda M S ^a   Pereira, Nátalli Z ^a   Mitsunari, Gabrielle E ^a   Duarte, Alberto J S ^a   Sato, Maria N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

activating receptors; HIV 1 infection; HIV exposed seronegative; inhibitory receptors; memory NK cells; NK cell subsets

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; NKG2C PROTEIN; UNCLASSIFIED DRUG; CD69 ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; KLRC2 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NCAM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEMORY CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; CD4 LYMPHOCYTE COUNT; CELL FUNCTION; CELL MATURATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD56; FEMALE; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; YOUNG ADULT;

EID: 84913558505     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000350     Document Type: Article

References (43)

1. Restrepo C, Rallon NI, Carrillo J, et al. Host factors involved in low susceptibility to HIV infection. AIDS Rev. 2011;13:30-40.
2. Miyazawa M, Lopalco L, Mazzotta F, et al. The "immunologic advantage" of HIV-exposed seronegative individuals. AIDS. 2009; 23:161-175.
3. Horton RE, McLaren PJ, Fowke K, et al. Cohorts for the study of HIV-1-exposed but uninfected individuals: Benefits and limitations. J Infect Dis. 2010;202(suppl 3):S377-S381.
4. Shacklett BL. Understanding the "lucky few": The conundrum of HIVexposed, seronegative individuals. Curr HIV/AIDS Rep. 2006;3:26-31.
5. Lama J, Planelles V. Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology. 2007;4:52.
6. Tomescu C, Chehimi J, Maino VC, et al. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: Requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J Immunol. 2007;179:2097-2104.
7. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune-response to human-immunodeficiency-virus (HIV) type-1 in seronegative homosexual men with recent sexual exposure to HIV-1. J InfectDis. 1992;165:1012-1019.
8. Mazzoli S, Trabattoni D, Caputo SL, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997;3:1250-1257.
9. Pinto LA, Sullivan J, Berzofsky JA, et al. ENV-specific cytotoxic T-lymphocyte responses in HIV seronegative health-care workers occupationally exposed to HIV-contaminated body-fluids. J Clin Invest. 1995; 96:867-876.
10. Kebba A. Antiretroviral therapy in sub-Saharan Africa: Myth or reality?. J Antimicrob Chemother. 2003;52:747-749.
11. Camara M, Dieye TN, Seydi M, et al. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: Influence of gender and condom use. J Infect Dis. 2010;201:835-842.
12. Alimonti JB, Kimani J, Matu L, et al. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol. 2006;84:482-485.
13. Erickson AL, Willberg CB, McMahan V, et al. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol. 2008;15: 1745-1748.
14. Restrepo C, Rallon NI, del Romero J, et al. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol. 2010;185:982-989.
15. Hirbod T, Kaul R, Reichard C, et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS. 2008;22:727-735.
16. Carrillo J, Restrepo C, Rallon NI, et al. HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein. AIDS. 2013;27:1375-1385.
17. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS. 2008;22: 595-599.
18. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39:733-740.
19. Guerini FR, Lo Caputo S, Gori A, et al. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. J Infect Dis. 2011;203: 1235-1239.
20. Habegger de Sorrentino A, Sinchi JL, Marinic K, et al. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina. Immunology. 2013;140:273-279.
21. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
22. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633-640.
23. Tarazona R, Casado JG, Delarosa O, et al. Selective depletion of CD56 (dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol. 2002; 22:176-183.
24. Mavilio D, Benjamin J, Daucher M, et al. Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A. 2003;100:15011-15016.
25. Alter G, Teigen N, Davis BT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005;106:3366-3369.
26. Scott-Algara D, Truong LX, Versmisse P, et al. Cutting edge: Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol. 2003;171:5663-5667.
27. Tomescu C, Duh FM, Lanier MA, et al. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS. 2010;24:2151-2160.
28. Montoya CJ, Velilla PA, Chougnet C, et al. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006;120:138-146.
29. Guma M, Cabrera C, Erkizia I, et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis. 2006;194:38-41.
30. Sun JC, Lopez-Verges S, Kim CC, et al. NK cells and immune "memory". J Immunol. 2011;186:1891-1897.
31. Mela CM, Goodier MR. The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J Infect Dis. 2007;195:158-159; author reply 159-160.
32. Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A, et al. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol. 2010;40:1418-1427.
33. Luther C, Warner K, Takei F. Unique progenitors in mouse lymph node develop into CD127+ NK cells: Thymus-dependent and thymusindependent pathways. Blood. 2011;117:4012-4021.
34. Gasteiger G, Hemmers S, Bos PD, et al. IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med. 2013;210:1179-1187.
35. Marras F, Nicco E, Bozzano F, et al. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci U S A. 2013;110:11970-11975.
36. Park YP, Choi SC, Kiesler P, et al. Complex regulation of human NKG2D-DAP10 cell surface expression: Opposing roles of the gammac cytokines and TGF-beta1. Blood. 2011;118:3019-3027.
37. Mantegani P, Tambussi G, Galli L, et al. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. Immunology. 2010;129:220-233.
38. Brunetta E, Fogli M, Varchetta S, et al. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood. 2009;114: 3822-3830.
39. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990;12:S701-S710.
40. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457:557-561.
41. Lopez-Verges S, Milush JM, Schwartz BS, et al. Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011;108:14725- 14732.
42. Braud VM, Allan DSJ, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
43. Nattermann J, Nischalke HD, Hofmeister V, et al. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther. 2005;10:95-107.